![5-([1,1′-Biphenyl]-4-ylmethyl)-N,N-dimethyl-1H-tetrazole-1-carboxamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F348836-5-11-biphenyl-4-ylmethyl-n-n-dimethyl-1h-tetrazole-1-carboxamide.webp&w=3840&q=75)
CAS 874902-19-9: 5-([1,1′-Biphenyl]-4-ylmethyl)-N,N-dimethyl-1H-tetrazole-1-carboxamide
Formula:C17H17N5O
InChI:InChI=1S/C17H17N5O/c1-21(2)17(23)22-16(18-19-20-22)12-13-8-10-15(11-9-13)14-6-4-3-5-7-14/h3-11H,12H2,1-2H3
InChI key:InChIKey=GZNIYOXWFCDBBJ-UHFFFAOYSA-N
SMILES:C(C=1N(C(N(C)C)=O)N=NN1)C2=CC=C(C=C2)C3=CC=CC=C3
Synonyms:- 1H-Tetrazole-1-carboxamide, 5-([1,1′-biphenyl]-4-ylmethyl)-N,N-dimethyl-
- 5-([1,1′-Biphenyl]-4-ylmethyl)-N,N-dimethyl-1H-tetrazole-1-carboxamide
- LY 2183240
Sort by
Found 5 products.
LY2183240
CAS:LY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM).Formula:C17H17N5OPurity:99.26%Color and Shape:SolidMolecular weight:307.35LY-2183240
CAS:Controlled ProductLY-2183240 is a potent, selective, and orally bioavailable inhibitor of the enzyme fatty acid amide hydrolase. This molecule has been shown to reduce inflammation by inhibiting the production of proinflammatory cytokines in animal models. LY-2183240 also acts as an agonist at the CB2 receptor and inhibits skin cancer tumor growth. It also displays an efficacy profile that is similar to other pharmacological agents used to treat inflammatory bowel disease and idiopathic urticaria.Purity:Min. 95%LY2183240
CAS:Controlled ProductApplications LY2183240 is a potent inhibitor of FAAH activity, and the uptake and enzymatic hydrolysis of anandamide. Synthetic CannabinoidsFormula:C17H17N5OColor and Shape:NeatMolecular weight:307.35
